ArticleACS chemical biology2025

Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor.

Sebastian Mandel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.